Long-acting CJC-1295: pharmacokinetic study
Teichman et al. · Journal of Clinical Endocrinology & Metabolism 91(3):799–805 · 2006
- Preparation
- Two randomized, placebo-controlled studies in healthy adults; investigational subcutaneous formulation
- Research question
- What pharmacokinetic and endocrine measurements characterize the long-acting construct?
- Measurements
- Pharmacokinetic and endocrine measurements of long-acting CJC-1295.
- Scope & limits
- Not unspecified or no-DAC material; no ipamorelin combination or ADVNC film inference.
DOI 10.1210/jc.2005-1536 · PMID 16352683

